# Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients

> **NCT03571620** · PHASE2 · COMPLETED · sponsor: **Qurient Co., Ltd.** · enrollment: 258 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Q301 Cream
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT03571620
- **Lead sponsor:** Qurient Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-21
- **Primary completion:** 2019-11-30
- **Final completion:** 2020-04-21
- **Target enrollment:** 258 (ACTUAL)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03571620

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03571620, "Safety and Efficacy Study of Q301 in Mild to Moderate Adolescents and Adults Atopic Dermatitis Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT03571620. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*